AstellasAstellas Pharma Inc.4503東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Revenue changed +5.6% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | 8.9% | —× | — |
| 2019 | 17.0% | 0.70× | 11.8% | 1.49× | 17.7% |
| 2022 | — | —× | 5.3% | —× | — |
| 2023 | — | —× | 4.1% | —× | — |
| 2024 | 1.1% | 0.53× | 0.6% | 1.89× | 1.1% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Revenue | 1,300,316 | 1,306,348 | 1,296,163 | 1,518,619 | 1,603,672 |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | 218,113 | 248,967 | 156,886 | 132,361 | 24,969 |
| Income tax | — | — | — | — | — |
| Net income attributable to owners | 164,679 | 222,265 | 124,086 | 98,714 | 17,045 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥331.7B | ¥311.1B | ¥316B | ¥376.8B | ¥335.7B |
| Total assets | ¥1.86T | ¥1.9T | ¥2.33T | ¥2.46T | ¥3.57T |
| Net assets | — | ¥1.26T | — | — | ¥1.6T |
EDINET (FSA Japan)
有価証券報告書－第21期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
訂正有価証券報告書－第18期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第17期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第16期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.